Study Code: GWCA0999; EudraCT Number: 2009-016529-32; A multicenter, non-comparative, open-label extension study to assess the long term safety of Sativex oromucosal spray (Sative; Nabiximols) as adjunctive therapy in patients with uncontrolled persist

Project: Research project

Project Details

StatusFinished
Effective start/end date4/24/12 → 4/23/15

Funding

  • GW Pharmaceuticals ( Award # ): $11,720.00